Moderna News - June 2026
🟢 MRNA is trading 5.5% up today after detailing expansion into autoimmune and cancer therapies
MRNA is trading 5.5% higher at $63.01 after investors reacted positively to the company's Science Day presentation detailing its expansion into autoimmune and...
🟢 MRNA is trading 4.8% up today, rebounding on continued FDA flu vaccine panel optimism
MRNA is trading 4.8% up at $62.17 as it rebounds from yesterday's sharp sell-off on continued optimism surrounding its flu vaccine pipeline. • The stock is...
🟢 Moderna Inc is trading 4.15% up today on new operating model, 2027-2028 product launch outlook, and favorable FDA flu vaccine data
Moderna Inc is trading 4.15% up now at $57.70, extending a sharp multi-day rally as investors react to the company’s new operating model, leadership...
🟢 Moderna Inc is trading 5.9% up today as flu vaccine study shows superior immunity
Moderna Inc is trading 5.9% up now at $55.22 after a study published in Nature Immunology showed its investigational flu vaccine, mRNA-1010, generated broader...
Moderna Flu Vaccine Triggers Broader Immunity, Nature Study Shows
Moderna’s investigational mRNA-1010 vaccine generates a broader and more durable immune response than standard flu shots, according to a study published in...
Moderna Vaccine Slashes Melanoma Recurrence 49%, Confirming Five-Year Durability
Moderna and Merck announced positive five-year results for their personalized mRNA cancer vaccine, intismeran autogene (mRNA-4157), combined with...